Linezolid for multidrug-resistant tuberculosis reply

被引：3
|
作者：
Chang, Kwok-Chiu [1 ]
Leung, Chi-Chiu [1 ]
Daley, Charles L. [2 ]
机构：
[1] Dept Hlth, TB & Chest Serv, Hong Kong, Hong Kong, Peoples R China
[2] Natl Jewish Hlth, Div Mycobacterial & Resp Infect, Denver, CO USA
来源：
LANCET INFECTIOUS DISEASES | 2013年 / 13卷 / 01期
关键词：
DRUG;
D O I：
10.1016/S1473-3099(12)70272-4
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：16 / 17
页数：2
相关论文
共 50 条
  • [31] Design and synthesis of novel quinoxaline derivatives as potential candidates for treatment of multidrug-resistant and latent tuberculosis
    Santivañez-Veliz, Mery
    Perez-Silanes, Silvia
    Torres, Enrique
    Moreno-Viguri, Elsa
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (09) : 2188 - 2193
  • [32] Population Pharmacokinetic and Concentration-QTc Analysis of Delamanid in Pediatric Participants with Multidrug-Resistant Tuberculosis
    Sasaki, Tomohiro
    Svensson, Elin M.
    Wang, Xiaofeng
    Wang, Yanlin
    Hafkin, Jeffrey
    Karlsson, Mats O.
    Mallikaarjun, Suresh
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (02)
  • [33] Cycloserine-Induced Insomnia and Psychosis in Multidrug-Resistant Pulmonary Tuberculosis-A Case Report
    Yadav, Sankalp
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (12)
  • [34] Factors Associated with Multidrug-resistant Tuberculosis: Comparison of Patients Born Inside and Outside of the Czech Republic
    Bartu, V.
    Kopecka, E.
    Havelkova, M.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2010, 38 (03) : 1156 - 1163
  • [35] Linezolid-resistant Mycobacterium tuberculosis: Will it impact the tuberculosis elimination programme?
    Bharadwaj, Renu
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2021, 154 (01) : 16 - 18
  • [36] Management of Multidrug Resistant Tuberculosis Preface
    Daley, Charles L.
    Caminero, Jose A.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 34 (01) : 44 - 59
  • [37] Multidrug-resistant Salmonella typhi: A worldwide epidemic
    Rowe, B
    Ward, LR
    Threlfall, EJ
    CLINICAL INFECTIOUS DISEASES, 1997, 24 : S106 - S109
  • [38] Exploiting the furo [2,3-b]pyridine core against multidrug-resistant Mycobacterium tuberculosis
    Fumagalli, Fernando
    Gil de Melo, Shaiani Maria
    Ribeiro, Camila Maringolo
    Solcia, Mariana Cristina
    Pavan, Fernando Rogerio
    Emery, Flavio da Silva
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (08) : 974 - 977
  • [39] The use of bedaquiline to treat patients with multidrug-resistant tuberculosis and end-stage renal disease: A case report
    Park, Seyeon
    Lee, Kyu Min
    Kim, Insu
    Mok, Jeongha
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2018, 76 : 88 - 90
  • [40] Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
    Ahmad, Nafees
    Ahuja, Shama D.
    Akkerman, Onno W.
    Alffenaar, Jan-Willem C.
    Anderson, Laura F.
    Baghaei, Parvaneh
    Bang, Didi
    Barry, Pennan M.
    Bastos, Mayara L.
    Behera, Digamber
    Benedetti, Andrea
    Bisson, Gregory P.
    Boeree, Martin J.
    Bonnet, Maryline
    Brode, Sarah K.
    Brust, James C. M.
    Cai, Ying
    Caumes, Eric
    Cegielski, J. Peter
    Centis, Rosella
    Chan, Pei-Chun
    Chan, Edward D.
    Chang, Kwok-Chiu
    Charles, Macarthur
    Cirule, Andra
    Dalcolmo, Margareth Pretti
    D'Ambrosio, Lia
    de Vries, Gerard
    Dheda, Keertan
    Esmail, Aliasgar
    Flood, Jennifer
    Fox, Gregory J.
    Frechet-Jachym, Mathilde
    Fregona, Geisa
    Gayoso, Regina
    Gegia, Medea
    Gler, Maria Tarcela
    Gu, Sue
    Guglielmetti, Lorenzo
    Holtz, Timothy H.
    Hughes, Jennifer
    Isaakidis, Petros
    Jarlsberg, Leah
    Kempker, Russell R.
    Keshavjee, Salmaan
    Khan, Faiz Ahmad
    Kipiani, Maia
    Koenig, Serena P.
    Koh, Won-Jung
    Kritski, Afranio
    LANCET, 2018, 392 (10150): : 821 - 834
12345